How Cancers Escape Immune Destruction and Mechanisms of Action for the New Significantly Active Immune Therapies: Helping Nonimmunologists Decipher Recent Advances

The Oncologist
Jonathan L MesserschmidtGerald L Messerschmidt

Abstract

With the Food and Drug Administration and other worldwide regulatory authorities' approval of ipilimumab (Yervoy), sipuleucel-T (Provenge), nivolumab (Opdivo), and pembrolizumab (Keytruda), oncologic therapy has now moved into noncancer cell targets within the immune system. For many nonimmunologists, understanding how these vastly different therapies work to improve survival, like no other therapies have in the past, is a challenge. The present report reviews the normal function of the immune system, how cancers escape the normal immune system, and how these new therapies improve immune system reactions against cancers. Oncologists have tremendous experience with therapies that target the cancer cells. New biologic agents have been rapidly introduced recently that target not cancer cells, but the patient's immune cells. The mechanisms of action of these immune-based biologic agents are within the host immune system. To understand these new biologic therapies, basic knowledge of normal and abnormal immune function is essential. The present report explains the up-to-date basic immune normal and abnormal function and prepares the oncologist to understand how the new drugs work, why they work, and why there are associated adverse ...Continue Reading

References

Sep 19, 1979·The Journal of Experimental Medicine·R UedaL J Old
Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·T E CareyL J Old
Aug 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A Lobo-YeoD Vergani
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A KnuthL J Old
Jan 1, 1995·Immunology Today·S Nagata, T Suda
Apr 7, 1995·Cell·G Berke
Jan 14, 1994·Cell·K A HogquistF R Carbone
Jun 13, 1996·Nature·S M AlamN R Gascoigne
Nov 1, 1996·Cancer Treatment Reviews·R J Papac
Nov 11, 1999·European Journal of Immunology·G MagistrelliY Delneste
Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·B Niakan
Sep 7, 2000·The Journal of Experimental Medicine·M J SmythJ A Trapani
Oct 9, 2002·Nature Immunology·Ursula GrohmannPaolo Puccetti
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Apr 22, 2003·Nature Medicine·Tyler J CurielWeiping Zou
Sep 1, 1956·Annals of Surgery·W H COLE, T C EVERSON
Apr 6, 1957·British Medical Journal·M BURNET
Nov 25, 2003·European Journal of Immunology·Christine Bourgeois, Corinne Tanchot
Dec 4, 2003·Nature Reviews. Immunology·Martien L Kapsenberg
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·David H MunnAndrew L Mellor
Aug 3, 2004·Nature Reviews. Immunology·Michael J Bevan
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jun KonishiMasaharu Nishimura
Dec 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·R Houston ThompsonEugene D Kwon
Mar 2, 2005·Nature Reviews. Immunology·Miriam Shapiro-Shelef, Kathryn Calame
Mar 18, 2005·Annual Review of Immunology·Rebecca J GreenwaldArlene H Sharpe
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuichiro OhigashiYoshiyuki Nakajima
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aikou OkamotoMitsuyoshi Urashima
Oct 18, 2005·Molecular and Cellular Biology·Richard V ParryJames L Riley
Feb 24, 2006·Nature Reviews. Immunology·Takashi Nagasawa
Feb 17, 2007·Nature Immunology·Arlene H SharpeGordon J Freeman
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takeo NomiYoshiyuki Nakajima
Jul 4, 2007·International Immunology·Taku Okazaki, Tasuku Honjo
Jan 29, 2008·Seminars in Immunology·Kirsten A FairfaxDavid M Tarlinton
Jan 10, 2009·Annual Review of Immunology·Jennifer E Smith-GarvinMartha S Jordan
Aug 15, 2009·Nature Reviews. Immunology·Rafi AhmedDouglas T Fearon
Mar 17, 2010·Current Opinion in Immunology·Misty R Jenkins, Gillian M Griffiths
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg

❮ Previous
Next ❯

Citations

May 16, 2017·Current Opinion in Oncology·Maëlle AnciauxAlain Hendlisz
Apr 20, 2018·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Emma Bondy-ChorneyMichael Downey
Oct 27, 2018·Journal of Cellular Physiology·Elham SafarzadehBehzad Baradaran
Dec 7, 2018·International Journal of Molecular Sciences·Suchithra Poilil SurendranYong Yeon Jeong
Jan 15, 2020·Bulletin of Mathematical Biology·Avner Friedman, Nourridine Siewe
Aug 29, 2020·Future Oncology·Maryam SoleimaniChristian Kollmannsberger
Mar 28, 2020·Journal of Cellular Physiology·Nasrollah JabbariJafar Rezaie
Aug 15, 2017·Current Oncology Reports·Jonathan L MesserschmidtGerald L Messerschmidt
Dec 6, 2018·Journal for Immunotherapy of Cancer·Junaid RajaHyun S Kim
Jan 22, 2021·Journal of Oral Biosciences·Lipsa BhuyanHarish Kumar
Jul 3, 2021·International Journal of Molecular Sciences·Mingjia YuSong Xue

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.